Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 252 is a human protein encoded by the TMEM252 gene located on chromosome 9. The protein is 170 amino acids in length and contains two transmembrane domains; it is predicted to be located in cellular membranes. The gene is mainly expressed in the kidney and small intestine, with additional lower levels in prostate, stomach, and several other organs. TMEM252 lacks characterized isoforms and shows evolutionary conservation in vertebrates but not invertebrates or plants. Its direct biological role is unknown, and it is not classified into major druggable protein families, such as receptors or enzymes. Preliminary research has identified TMEM252 among genes associated with poorer prognosis in triple-negative breast cancer and in gene-association studies for frontotemporal dementia and/or amyotrophic lateral sclerosis. However, no mechanism, direct pathogenic role, or drug associations have been established to date.
None. No drugs known to target this molecule, thus no mechanisms described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 252 (TMEM252).